McNeish Alister J, Dora Kim A, Garland Christopher J
Department of Pharmacy and Pharmacology, The University of Bath, Claverton Down, Bath, BA2 7AY, UK.
Stroke. 2005 Jul;36(7):1526-32. doi: 10.1161/01.STR.0000169929.66497.73. Epub 2005 Jun 2.
Endothelium-derived hyperpolarizing factor (EDHF) and K+ are vasodilators in the cerebral circulation. Recently, K+ has been suggested to contribute to EDHF-mediated responses in peripheral vessels. The EDHF response to the protease-activated receptor 2 ligand SLIGRL was characterized in cerebral arteries and used to assess whether K+ contributes as an EDHF.
Rat middle cerebral arteries were mounted in either a wire or pressure myograph. Concentration-response curves to SLIGRL and K+ were constructed in the presence and absence of a variety of blocking agents. In some experiments, changes in tension and smooth muscle cell membrane potential were recorded simultaneously.
SLIGRL (0.02 to 20 micromol/L) stimulated concentration and endothelium-dependent relaxation. In the presence of NG-nitro-L-arginine methyl ester, relaxation to SLIGRL was associated with hyperpolarization and sensitivity to a specific inhibitor of IKCa, 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole (1 micromol/L), reflecting activation of EDHF. Combined inhibition of KIR with Ba2+ (30 micromol/L) and Na+/K+-ATPase with ouabain (1 micromol/L) markedly attenuated the relaxation to EDHF. Raising extracellular [K+] to 15 mmol/L also stimulated smooth muscle relaxation and hyperpolarization, which was also attenuated by combined application of Ba2+ and ouabain.
SLIGRL evokes EDHF-mediated relaxation in the rat middle cerebral artery, underpinned by hyperpolarization of the smooth muscle. The profile of blockade of EDHF-mediated hyperpolarization and relaxation supports a pivotal role for IKCa channels. Furthermore, similar inhibition of responses to EDHF and exogenous K+ with Ba2+ and ouabain suggests that K+ may contribute as an EDHF in the middle cerebral artery.
内皮衍生超极化因子(EDHF)和钾离子是脑循环中的血管舒张剂。最近,有研究表明钾离子参与外周血管中EDHF介导的反应。本研究对脑动脉中蛋白酶激活受体2配体SLIGRL引发的EDHF反应进行了特征描述,并用于评估钾离子是否作为EDHF发挥作用。
将大鼠大脑中动脉安装在线式或压力肌动描记仪上。在存在和不存在多种阻断剂的情况下,构建对SLIGRL和钾离子的浓度-反应曲线。在一些实验中,同时记录张力和平滑肌细胞膜电位的变化。
SLIGRL(0.02至20 μmol/L)刺激浓度依赖性和内皮依赖性舒张。在存在N-硝基-L-精氨酸甲酯的情况下,对SLIGRL的舒张与超极化以及对IKCa特异性抑制剂1-[(2-氯苯基)二苯基甲基]-1H-吡唑(1 μmol/L)的敏感性相关,反映了EDHF的激活。用Ba2+(30 μmol/L)联合抑制KIR和用哇巴因(1 μmol/L)抑制Na+/K+-ATP酶可显著减弱对EDHF的舒张。将细胞外[K+]提高到15 mmol/L也刺激平滑肌舒张和超极化,联合应用Ba2+和哇巴因也可减弱这种反应。
SLIGRL在大鼠大脑中动脉中引发EDHF介导的舒张,其基础是平滑肌超极化。EDHF介导的超极化和舒张的阻断特征支持IKCa通道起关键作用。此外,用Ba2+和哇巴因对EDHF和外源性钾离子反应的类似抑制表明钾离子可能作为EDHF在大脑中动脉中发挥作用。